SEC Form 4 · accession 0001209191-18-036693
ChronoScale Holdings Corp · CHRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Max Scheder-Bieschin
Officer — Chief Financial Officer
Period of report
May 10, 2018
Accepted (ET)
Jun 8, 2018 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001549084
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 10, 2018 | M | 9,250 | — | A | 81,110 | D | |
| Common Stock | May 10, 2018 | F | 4,151 | $1.5052 | D | 76,959 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 10, 2018 | M | 9,250 | D | — | — | Common Stock | 9,250 | 27,750 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Ekso Bionics Holdings, Inc. common stock.
- F2The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.